Israel is blocked for a moment by covid-19 until at least mid-October, but that has not stopped its medical generation industry; in fact, the pandemic has driven demand for some of its products. a CEO of a public company and two startups reveal two ubiquitous topics:
Olive Tree Ventures Invests in Fast-Growing Virtual Health Companies
Olive Tree Ventures is an Israeli-based venture capital fund that invests in new virtual fitness companies. Olive Tree manages $155 million in assets and has provided capital to nine new companies. You see significant opportunities in the virtual fitness box, a market that has grown through 150% since 2017 and is expected to have $540 billion in profits through 2025. Behind this expansion is the generation of industry that improves the rates of diagnosis of serious diseases and develops new remedies for terminal diseases, according to Olive Tree.
Olive Tree founder has impressive experience. As Amir Lahat, managing spouse of Olive Tree Venture said in an interview on September 1, “I in the army, not in the 8200s. Beyond the lines, at the age of 20, commanding more than a hundred people. I studied engineering at Tel Aviv University. 3Com I acquired Telrad, [a company where I was a formula engineer]. I stayed there for 4 years, then co-founded Atrica, which was supported through Accel and Benchmark. . Nokia acquired it [in 2008 for less than $100 million, according to EETimes]. I joined the Business Venture Group in Nokia. Je returned to Israel with 3 young people and founded Olive Tree in 2015 with 3 virtual fitness spouses”.
Olive Tree has invested in corporations that gain advantages from the desire to diagnose and monitor the outdoor fitness of medical practices, a trend that has accelerated through social estating in reaction to the pandemic. “In recent years, there has been a building in the outdoor surveillance and diagnostic tests of medical offices. Our corporations come with TytoCare (which I wrote in May) – which allows patients to perform medical tests at home and send the effects to doctors; ContinUse Biometrics – contactless follow-up of important symptoms in elderly and chronically ill patients, and Scope, virtual microscopy,” he said.
Lemonaid Health, a San Francisco-based portfolio company in Oliviers, is booming. Its service allows patients to chat online with a doctor to “give birth or safe prescription drugs to treat undeniable conditions, such as urinary tract infections or erectile dysfunction,” Lahat told me, “Lemonaid is developing incredibly fast, succeeds and operates in 50 states through partnerships with doctors and online drug providers. “
Itamar Medical offers faster and less expensive sleep apnea diagnosis
Itamar Medical, a publicly traded medical generation company in Cesarea, Israel and headquartered in Atlanta, Georgia, is helping doctors diagnose and control sleep apnea. Its key product, WatchPAT, a disposable device for sleep apnea, is advertised in the United States and Japan. Europe.
The expansion of Itamar Medical is driven by patients looking for a diagnosis and remedy for sleep apnea at home. Revenue for the current quarter of 2020 rose 21% to $8. 9 million, while WatchPAT sales in the United States increased by 31% to $6. 6 million in the quarter, according to the company.
He joined Itamar Medical, founded in Caeseria, Israel, with offices in the United States in Atlanta, Georgia. “When I joined [as CEO in July 2013 at Itamar Medical] a numb, indebted and uns growing company. I looked to fix it. The concept of integrating sleep apnea with atrial fibrillation. Sleep apnea affects 15% of the adult population, about 60 million people. When sleep apnea patients fall asleep, their padded tissues collapse, blocking their airlines 10 to 15 times per hour. They wake up exhausted, damage the central tissue and is a cause of atrial fibrillation».
Itamar Medical manufactures a device that diagnoses sleep apnea. “We have a medical device, called peripheral arterial tonemetric check (PAT), that can run into sleep apnea in a less expensive and less complicated way for the patient. It’s hard to convince the industry”. to adopt PAT because sleep doctors weren’t paid for it. Night polysomnography control, in which a patient spends the night in a sleep clinic, will pay a sleep doctor $2,000 while the PAT costs $200. “
Since 2013, Glick has driven the market capitalization of Itamar Medical. “Since 2013, the company’s market space capitalization has increased from $50 million to [$314 million as of September 18]. I joined because I knew AFib, I think I can create Israeli jobs and we had no competition. The key to reviving Itamar was to verify to convince cardiologists, who add up to 35,000, [much more than] the 5,000 sleep doctors. We were able to show cardiologists that PAT can help in a threat to the FA. -19, 90% of sleep apnea tests were performed in the sleep clinic, only 10% were performed through PAT. Since Covid-19, sleep labs have closed, which has been a great help to us. “
For more than two and a half years, Itamar has been promoting WatchPAT. “One of the first devices sold to doctors. We found that the logistics of a patient returning the $200 device to their [expensive] doctor. We’ve created a completely disposable edition [, WatchPAT,] that uses a smartphone app to collect and transmit check results. Since its launch, our sales have grown from $3. 5 million to $4 million quarterly to $10 million in line with the quarter,” Glick said.
Theator helps surgeons make better decisions
Theator operates Minute, a platform that shows the moments of a successful operation, performed through a surgeon of the same delight with a patient in the same condition, before a surgeon is about to perform the operation.
As Tamir Wolf, executive director and co-founder of Theator, explained in an interview on September 15, “I am from Haifa and received a Doctorate in Medicine/Doctorate at Technion. I started working as a doctor on the Israeli equivalent of Seal Team 6. During the Second Lebanon War, I supported a missile-led unit. There were thirteen wounded and I was the only doctor. Operating two of my friends under the retreating chimney. Fortunately, they’re alive. I’ve never experienced this before. What am I doing? You may have used the most experienced people recommendation. “
After a few more years in the army, I needed a break. He went to paint at a medical device company in Cambridge, Massachusetts, and then at Harvard Business School. “To my mother’s disappointment, I made a decision that perhaps simply had a greater effect on a larger scale as an entrepreneur than as a clinician. The challenge he sought to solve materialized through two cases of appendicitis that I dealt with at other hospitals seven miles away in New York. bad decisions since the first, my boss, entered the hospital, almost died; the second, my wife, had abdominal pain; 12 hours after he entered the hospital, he returned home and healed; such far-fetched variability in 2016 made no sense. “
Wolf co-founded Theator in Menlo Park, California, to get results for patients by helping surgeons make more important decisions. “Since the 17th century, surgery has worked in the style of being informed in which Americans receive information from experienced surgeons on how to make smart decisions. The purpose was to provide analyzed surgical photographs, a climax coil that condenses, for example, five hours of surgical video, which can be searched based on the surgeon’s point of experience, medical procedure and patient disease and condition. flagship film to prepare for your next surgery. We have developed a set of rules that annotate everything to create the focus coil for an hour and hour operation 15 minutes after the end. I was able to marry my partner. founder Dotan Asselmann – who was pc’s vision assistant in 8100 [an elite unit of the Israel Defense Forces].
Theator, which raised $3 million in initial investment in April 2019, operates a business-to-business model. The company aims at a usable and addressable market of $6. 2 billion to minimize the headaches of general surgery, Theator partners with so-called tour providers. – who record videos of surgeries. Corporate fees for general surgeons, gynecologists, urologists and others, a monthly or per-shift fee. Lately, the tador is carrying out pilot projects with pioneers such as leading professional companies, McGill University and others.
StuffThatWorks voices drug development
At Waze, Elish has solved a major marketing problem: achieving a critical mass of users eager to provide accurate and timely reports on road conditions. As he explained in an interview on September 3, “How are other people asked to register and make a contribution [to a crowdsourcing site when it is too small to offer] value?You’ll have to be very professional. Users deserve to be proud to make a contribution to the realization of vision and registration for value creation. It’s an expectations definition query: it will take a year or two to add more value. »
STW was presented as a solution to a challenge facing elish. “While working at Google after the waze acquisition, my daughter suffered from a chronic illness. This didn’t have to be life threatening. It caused suffering in the circle of relatives to put it worse. She frantically searched online each and every night a transparent idea There must be something out there: a blog post by a teenager I finally discovered a remedy in Israel taking it and within 3 weeks [her symptoms] disappeared.
STW aims to focus the innovation schedule of medical and pharmaceutical generation corporations more directly on patient outcomes. “There are 10,000 chronic diseases affecting 6. 5 billion other people in the world and the stage is getting worse. [With a few exceptions], there is no data on what happens to these patients. Anyone with money, such as pharmaceutical companies, focuses on a subset of patients with no data on what works. There is no comparison between methods. We are collaborating to gather real global evidence that will divert attention to what works for patients,” Elish said.
STW has been running stealthily for two years. In July 2020, it raised $9 million, according to TechCrunch. He has knowledge of more than a hundred other conditions, out of 220,000 participants, with 12 million knowledge points, Elish said.
Elish left Google and co-founded STW with two others. According to TechCrunch, they included CTO Ron Held, a “trained mathematician and former head of an IDF intelligence team,” and leading knowledge scientist Yossi Synett, who is “an expert in learning devices, AI and practical analysis . . »
STW is helping patients and medical researchers. It provides a forum for patients to express their fears and exchange recommendations on effective and useless treatments. It also provides the patient’s voice in the procedure for upcoming treatments for the disease.
As Dr. Amir Tirosh, Director of the Division of Endocrinology, Diabetes and Metabolism at Sheba Hospital – Tel Ha Shomer and Assistant Professor of Harvard Medical School, told me on September 15: “[As Chairman of the STW Subcommittee on Type 1 Diabetes] I am very pleased that Yael uses the new social media to break a taboo in the industry. Let patients tell us what they think is important. Pharmaceutical corporations control drugs as opposed to a placebo because regulators require it. But this leaves many unanswered questions about effectiveness. , appearance effects and additional approaches ».
Scientists in STW databases see the express symptoms of the disease in the context of the environmental intellectual points that cause the disease and in relation to other conditions. Tirosh said: “STW databases allow medical science to map tens of thousands of patients worldwide with weather maps, air pollutants, and other physical and intellectual conditions. For example, polycystic ovary syndrome is a condition with physical symptoms, such as increased hair expansion and a threat of diabetes, as well as intellectual disorders, such as depression and anxiety, Tirosh explained.
Israel’s virtual fitness industry aims to solve patient pain. The existing pandemic makes the need for such responses urgent. These corporations can offer exciting acquisition opportunities for established operators eager to grow.
I left U. S. corporations in 1994 and established a risk capital and control consulting firm (http://petercohan. com). Following the movements of 1981 when he was
I left U. S. corporations in 1994 and established a risk capital and control consulting firm (http://petercohan. com). I started tracking movements in 1981 when I was at MIT High School and first analyzed generational movements as a guest at CNBC in 1998. . I became a Contributor to Forbes in April 2011. My fourteenth eBook, published in February 2019, is “Climb your start-up: master the four steps of the $10 billion idea. “I gave the impression 8 times in the 2016 documentary “We The People: The Market Basket Effect” (http://www. themarketbasketeffect. com/). I also teach business strategy and entrepreneurship at Babson College in Wellesley, Mass. (Http://www. babson. edu/Academics/faculty/profiles/Pages/Cohan-Peter. aspx)